Cardura
These highlights do not include all the information needed to use CARDURA safely and effectively. See full prescribing information for CARDURA. CARDURA (doxazosin) tablets, for oral use Initial U.S. Approval: 1990
eefc47bc-c10f-49bb-8ef7-5999f798ab39
HUMAN PRESCRIPTION DRUG LABEL
Jan 20, 2022
ROERIG
DUNS: 829076996
Products 8
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
doxazosin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
doxazosin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
doxazosin mesylate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
doxazosin mesylate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (8)
doxazosin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
doxazosin mesylate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (8)
doxazosin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
doxazosin mesylate
Product Details
FDA regulatory identification and product classification information